Skip to content

Doctors herald lung cancer breakthrough with new drugs

By Catholic Online (NEWS CONSORTIUM)
5/19/2014 (2 years ago)
Catholic Online (www.catholic.org)

Miracle drug 'Nivolumab' found to have remarkable success

A diagnosis of lung cancer today is tantamount to a death sentence. Cancerous cells found in the lungs quickly spread to the brain, liver and kidneys, and those who are diagnosed usually die within months. There is hope: a new miracle drug, "nivolumab," has recently reported a high success rate.

Scientists are reporting incredible success treating advanced lung cancer with drugs such as nivolumab.

Scientists are reporting incredible success treating advanced lung cancer with drugs such as nivolumab.

Highlights

By Catholic Online (NEWS CONSORTIUM)
Catholic Online (www.catholic.org)
5/19/2014 (2 years ago)

Published in Health

Keywords: Lung cancer, nivolumab, success, trials


LOS ANGELES, CA (Catholic Online) - Scientists say that new drugs have cleared tumors that have spread throughout lung cancer patients' whole bodies. Some researchers are even talking of the new immunotherapy drugs effectively curing patients of the disease.

Scientists are reporting incredible success treating advanced lung cancer with drugs such as nivolumab.

Starvation takes no vacation --

"Stellar" trial results for the antibody drug will be presented at the world's biggest cancer conference, for the American Society of Clinical Oncology, in Chicago. According to researchers, a quarter of 129 U.S. patients with advanced lung cancer have survived at least two years after starting nivolumab.

"You would expect patients in that group to survive a few months, if you're lucky. So to get 24 per cent living two years is extraordinary," Dr. Mick Peake of Glenfield Hospital in Leicester said.

One test subject, a man in his forties had lung cancer which had spread to his liver, brain, bones and adrenal glands, he said. "By the time it's spread that far, you don't expect patients to last more than a couple of months. But in a recent scan, his doctor could not find any evidence of residual disease."

Peake said it was also remarkable that so many were responding to this treatment. Of those treated with the optimum dose, 45 percent were alive after two years.

"In any trial you get the odd patient who does very well, but this is an order of magnitude above that."

One of a new class of drugs, nivolumab is among what is term anti-PD1s and anti-PDL1s, which help the immune system "see" that tumors are deadly foes.

"Tumors develop a 'cloak,' like a 'Star Wars' force field, around themselves. This stops the immune system attacking them," Dr. Peake says.

"These drugs take that force field away and allow the body's immune response to fight the tumor. The beauty is we do not have the adverse side effects of conventional treatment."

Professor Dean Fennell, who has been treating British patients with a similar drug, MK3475, said, "This is an enormous deal. There are patients on treatment who've been going an incredibly long time."

Dr. Julie Brahmer of John Hopkins Sidney Kimmel Comprehensive Cancer Centre in Baltimore, who has helped spearhead U.S. nivolumab trials, said it was "a little early" to call it a cure. But she added: "That's what our hope is."

---


'Help give every student and teacher Free resources for a world-class moral Catholic education'


Copyright 2017 - Distributed by THE CALIFORNIA NETWORK

Pope Francis Prayer Intentions for MARCH 2017
Support for Persecuted Christians.
That persecuted Christians may be supported by the prayers and material help of the whole Church.


Comments


More Health

Two-thirds of cancers may have a surprising cause that we can do nothing about Watch

Image of Scientists have found that two-thirds of all cancer cases may be the result of random, bad-luck mutations.

If you are afraid of cancer, we have bad news. There may be little way to avoid the dreaded disease. A new study affirms that two-thirds of ... continue reading


Neil Gorsuch and end-of-life care: What ethical stance does he take? Watch

Image of Neil Gorsuch offers his views on end-of-life care.

Supreme Court nominee Neil Gorsuch made a crucial ethical distinction in his response to questions about doctor-prescribed suicide during ... continue reading


'Three-parent babies' are coming. We are resistant to wisdom, let's pray we are resistant to the consequences Watch

Image of Designer babies have arrived.

British doctors have been given the OK to create embryos from three parents to prevent genetic diseases. The first such child could be born ... continue reading


California could REBEL against Obama AND Trump and build its own single payer system, but who will pay for it? Watch

Image of California may be going alone on several things as the Federal government cuts back what it does for the states.

California is a large, wealthy state dominated by Democrats. Its economy, even if a bad year, is among the top ten in the world. The state ... continue reading


31-year-old man regains life after 'miraculous' face transplant Watch

Image of

After ten years, a 60-person medical team, and a 56-hour surgery, 31-year-old Andy Sandness received the first steps into truly getting his ... continue reading


Never Miss any Updates!

Stay up to date with the latest news, information, and special offers.

Catholic Online Logo

Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.